News
Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference
Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the Wells Fargo Healthcare Conference on Thursday, Sept. 5, 2024.
Bernard Zovighian, chief executive officer
EQS-News: Eckert & Ziegler opens new facilities for radiopharmaceutical plant engineering in Dresden
EQS-News: Eckert & Ziegler opens new facilities for radiopharmaceutical plant engineering in Dresden
Premier, Inc. Reports Fiscal-Year 2024 Fourth-Quarter and Full-Year Results
Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2024 fourth quarter and full year ended June 30, 2024
Premier, Inc. Appoints Glenn Coleman as Chief Administrative and Financial Officer
Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that Glenn Coleman, CPA, was unanimously appointed by the Board of Directors to serve as
AllSpire Health Partners Selects Premier, Inc. as its National GPO
Premier, Inc. (NASDAQ: PINC), a leading technology-enabled healthcare improvement company, today announced that it has been selected by AllSpire Health GPO, LLC (AllSpire), a regional group
LivaNova to Present at the Baird Global Healthcare Conference
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Baird 2024 Global
Inaugural Humana Community Day Promotes Health Benefits of Volunteerism
Several thousand green-shirted Humana employees will volunteer in Louisville on Aug. 21, marking the anniversary of the company’s founding, demonstrating Humana’s commitment to its hometown and
QuidelOrtho to Participate in Upcoming Investor Conferences
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine
Humana Announces New Veteran Hiring Strategy and Recognition as Top Veteran-Friendly Company
Humana Inc. (NYSE: HUM), a leading health and well-being company, launches a refreshed military-connected hiring strategy and earns recognition by U.S. Veterans Magazine as a Top Veteran-Friendly
Agilent Announces Innovative J&W 5Q GC/MS Columns for Superior Gas Chromatograph Performance
Agilent Technologies Inc., (NYSE: A) today announced the release of its new Agilent J&W 5Q GC/MS Columns, representing a major advance in gas chromatography/mass spectrometry (GC/MS) column
EQS-News: Eckert & Ziegler becomes European contract manufacturer for Telix's innovative Phase III ProstACT GLOBAL study
EQS-News: Eckert & Ziegler becomes European contract manufacturer for Telix's innovative Phase III ProstACT GLOBAL study
EQS-News: Eckert & Ziegler Continues Sales and Earnings Growth in the First Half of 2024
EQS-News: Eckert & Ziegler Continues Sales and Earnings Growth in the First Half of 2024
Premier, Inc. Declares Quarterly Cash Dividend
Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.21 per share of Class A common
The Trust for the National Mall and Humana Announce New Programming and Advance Court Reservation Sign-up Date for National Mall of Pickleball 2024
In honor of National Pickleball Day, The Trust for the National Mall and Humana (NYSE: HUM) announce exciting program details for the three-day monumental event, National Mall of Pickleball
STAAR Surgical Reports Second Quarter 2024 Results
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today
Inogen Announces Second Quarter 2024 Financial Results
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended June 30
EQS-News: Eckert & Ziegler extends GalliaPharm® availability to the entire European Economic Area
EQS-News: Eckert & Ziegler extends GalliaPharm® availability to the entire European Economic Area
Agilent Receives FDA Approval for MAGE-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy
Agilent Technologies Inc., (NYSE: A) today announced that it has received FDA approval for the use of MAGE-A4 IHC 1F9 pharmDx (SK032) as a diagnostic tool to aid in identifying patients with
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Simulations Plus Releases DILIsym® X
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the
QuidelOrtho Reports Second Quarter 2024 Financial Results
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs, and